Cite
HARVARD Citation
Zhang, X. et al. (2022). PHGDH Inhibitor CBR-5884 Inhibits Epithelial Ovarian Cancer Progression via ROS/Wnt/β-Catenin Pathway and Plays a Synergistic Role with PARP Inhibitor Olaparib. Oxidative medicine and cellular longevity. p. . [Online].